Video Player is loading.
HFSA 2023 - Navigating MCS Selection Amidst the RCT Evidence Gap.
By
Getinge
FEATURING
David Baran
By
Getinge
FEATURING
David Baran
Welcome to the fourth presentation within the session, "HFSA 2023: Reviving Hearts Renewing Lives: The Evolution of Counterpulsation in Heart Failure," from the 2023 Heart Failure Society of America Annual Scientific Meeting.
Navigating MCS Selection Amidst the RCT Evidence Gap.
David A. Baran, MD, FACC, FSCAI, FHFSA, Cleveland Clinic, Weston, FL.
This engaging presentation explores the challenges of selecting mechanical circulatory support devices in the context of cardiogenic shock, focusing on the limitations of randomized controlled trials and practical decision-making strategies. Gain valuable insights into the use of IABP, Impella, ECMO, and other devices to improve patient outcomes.
To watch the full-length session, click here.
Comments 0
Login to view comments.
Click here to Login
